Initial Fields Sample Clauses

Initial Fields. The Research Program shall initially include the following Fields: (i) the Electroluminescent Field, which shall be defined as electroluminescent materials and electroluminescent devices for back-light and display applications; (ii) the Catalysis Field, which shall be defined as catalysts for conversion of benzene to aniline; and (iii) the X-Ray Phosphors Field, which shall be defined as x-ray phosphors for general radiography applications. (a) Addition of Butyl Rubber Field. Upon written agreement of the parties, including approval by Prof. Dr. ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇resenting the Bayer Rubber Business Group, on or before May 1, 1998 setting forth mutually agreeable terms which may include amendments to sections of this Agreement, the Research Program may be expanded to include the Butyl Rubber Field, which shall be defined as catalysts or improvements of process parameters (i.e., reagents, formulations or conditions) for synthesizing poly(isobutylene) or butyl rubber through high temperature polymerization of isobutylene in non-halogenated solvents. It is understood that upon addition of the Butyl Rubber Field to the Research Program, Symyx will dedicate six (6) FTEs to research activities in the Butyl Rubber Field during the period from May 1, 1998 to March 1, 1999, and will dedicate seven (7) FTEs to research activities in the Butyl Rubber Field during the period from March 1, 1999 to March 1, 2000.
View Source
Initial Fields. The Research Program shall initially include the following Fields: (i) [******]
View Source
Initial Fields. The Research Program shall initially include the following Fields: [******]. (a) Addition of [******] Field. Upon written agreement of the parties, including approval [******], on or before May 1, 1998 setting forth mutually agreeable terms which may include amendments to sections of this Agreement, the Research Program may be expanded to include the [******] Field, which shall be defined as [******]. It is understood that upon addition of the [******] Field to the Research Program, Symyx will dedicate [******] FTEs to research activities in the [******] Field during the period from May 1, 1998 to March 1, 1999, and will dedicate [******] FTEs to research activities in the [******] Field during the period from March 1, 1999 to March 1, 2000. (b) Bayer Election to Reduce [******] Field. In the event that the * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. 3 Research Program has not been expanded to include one or more Projects concerning [******] (including without limitation the Projects described in Section 2.3) on or before June 1, 1998, then Bayer may elect to reduce the number of Symyx FTEs within the [******] Field from [******] FTEs to [******] FTEs for the period from the effective date of such reduction to March 1, 1999, and from [******] FTEs to [******] FTEs for the period from March 1, 1999 to March 1, 2000. In the event that Bayer so elects to reduce the [******] Field, (i) the funding payments from Bayer to Symyx will be reduced as set forth in Section 6.2.1(a), and (ii) Symyx shall not be obligated to utilize more than an average of [******]) FTEs per year in the [******] Field from the effective date of such election to March 1, 1999 and [******] FTEs per year in the [******] Field from March 1, 1999 to March 1, 2000.
View Source

Related to Initial Fields

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Joint Inventions For Subject Inventions conceived or first actually reduced to practice under this Agreement that are joint Subject Inventions made by CONTRACTOR and USER, each Party shall have the option to elect and retain title to its undivided rights in such joint Subject Inventions.